IF YOU HAVE MODERATE-TO-SEVERE PLAQUE PSORIASIS
There may be a clearer tomorrow,
starting today with ILUMYA™

Scroll

CLEARER STARTS HERE

Most people with moderate-to-severe plaque psoriasis were clear or almost clear with just 2 doses of ILUMYA™ (at 12 weeks). That means fewer symptoms like plaques, redness, and those flakes that seem to follow you around.

See Results

Individual results may vary.

FEWER DOSES

ILUMYA™ is dosed just 4 times a year after 2 initial doses.

DISCOVER DOSING
WITH ILUMYA™

LASTING RESULTS

Studies in people with moderate-to-severe plaque psoriasis showed that ILUMYA™ continued to clear their skin over time, even after 3 years on therapy.

See Timeline

Individual results may vary.

ILUMYA™ WORKS DIFFERENTLY

ILUMYA™ is a biologic medicine that helps restore order to your immune system by blocking a key molecule that makes psoriasis worse.

WATCH ILUMYA™
IN ACTION

ILUMYA™ is not for everyone. Ask your doctor if ILUMYA™ could be the treatment you’re looking for.

Support to keep you going

Enroll in ILUMYA SUPPORT Lighting the Way™ to see if you’re eligible to receive ILUMYA™ at low or no cost.

Get the benefits
eBook Gif
FREE eBOOK: Ready, Set, PsO!

Discover helpful tips for living more comfortably with moderate-to-severe plaque psoriasis.

Ready, Set, PsO! is a collection of useful life hacks from people just like you who have found interesting ways to master their psoriasis symptoms.

You will learn:

  • How to manage symptoms at work
  • Which foods to eat to avoid flares
  • How to talk to friends, family, or a date
  • And much, much more

COMPLETE THE FORM BELOW TO GET YOUR FREE COPY!

All fields required.

By clicking the Submit button, I authorize Sun Pharmaceutical Industries, Inc., its affiliates, subsidiaries, and third-party agents to contact me by mail and/or email to provide information on dermatology products, programs, services, and disease-state information and/or utilize my information for market research or analytics. Sun Pharmaceutical Industries, Inc., its affiliates, subsidiaries, and third-party agents will not utilize or distribute my personal information outside the above terms of consent.

Please refer to our Privacy Policy for more information.